PT Kalbe Farma Tbk has officially reinforced its commitment to implementing sustainable business practices. By integrating Environmental, Social, and Governance (ESG) principles across all operational lines, the company strives to create a positive impact on the healthcare ecosystem while improving the quality of life for the broader community.
As a concrete manifestation of this policy, Kalbe has optimized energy efficiency at its manufacturing facilities and transitioned to more environmentally friendly packaging materials. In the distribution sector, the company has begun electrifying its motorcycle fleet to reduce carbon emissions, alongside actively running reforestation programs in various regions across Indonesia.
In terms of healthcare services, Kalbe continues to expand product accessibility for various segments of society by aiming to localize the production of raw pharmaceutical materials, medical devices, and diagnostics. This step is considered strategic for reducing operational costs while improving product affordability for domestic consumers, supported by health education initiatives such as diabetes prevention.
Corporate governance aspects are also a major highlight through the strengthening of regulatory compliance and the strict implementation of employee code of conduct. Transparency regarding sustainability performance is routinely published through annual reports and dedicated digital channels to ensure accountability to stakeholders.
This dedication has yielded significant results, earning an AA rating from the MSCI rating agency and a Medium Risk predicate from Morningstar Sustainalytics. Various other recognitions, such as 'Trusted Diamond Achievement in Emission Transparency' and 'ESG Leadership', further consolidate Kalbe's position as a leader in sustainability transformation within the national pharmaceutical industry.
